|
Volumn 361, Issue 13, 2009, Pages 1310-1312
|
Treating childhood leukemia without cranial irradiation [1]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ANTITHROMBIN III;
ASPARAGINASE;
ANTITHROMBIN;
ACUTE LYMPHOBLASTIC LEUKEMIA;
CANCER CHEMOTHERAPY;
CENTRAL NERVOUS SYSTEM;
CHILDHOOD LEUKEMIA;
EVENT FREE SURVIVAL;
FOLLOW UP;
HUMAN;
LETTER;
OUTCOME ASSESSMENT;
OVERALL SURVIVAL;
PRIORITY JOURNAL;
SKULL IRRADIATION;
CHEMICALLY INDUCED DISORDER;
CHILD;
NOTE;
OCCLUSIVE CEREBROVASCULAR DISEASE;
BLOOD LEVEL;
HIGH RISK PATIENT;
MORBIDITY;
THROMBOSIS;
THROMBOSIS PREVENTION;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
ANTITHROMBIN III;
ASPARAGINASE;
CHILD;
CRANIAL IRRADIATION;
HUMANS;
INTRACRANIAL THROMBOSIS;
PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;
|
EID: 70349464627
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/nejmc091522 Document Type: Letter |
Times cited : (3)
|
References (1)
|